Technical Analysis for HEM - Hemostemix Inc.

Grade Last Price % Change Price Change
A 0.100 11.11% 0.010
HEM closed up 11.11 percent on Friday, November 1, 2024, on 31 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Wide Bands Range Expansion 11.11%
Overbought Stochastic Strength 11.11%
Gapped Down Weakness 11.11%
New Uptrend Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%

   Recent Intraday Alerts

Alert Time
Rose Above 10 DMA 1 day ago
Up 5% 1 day ago
Up 3% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hemostemix Inc is a Canada-based clinical-stage biotechnology company. The Company's principal business is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions, including critical limb ischemia (CLI). The Company's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of CLI. ACP-01 is in a Phase II clinical trial in Canada, South Africa and the United States. The Company also focuses on developing other cell products, such as bone cell precursors (BCPs), myocardial cell precursors (MCPs) and neural cell precursors (NCPs). It operates in Canada and Israel. The Company has approximately 2,200 square foot research and manufacturing facility in Ness Ziona, Israel. Hemostemix Limited is the subsidiary of the Company.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Nature Clinic Biotechnology Therapy Biology Clinical Trial Bone Hypertension Cell Biology Stem Cells Cell Products Cell Therapy Manufacturing Facility

Is HEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.12
52 Week Low 0.035
Average Volume 206,417
200-Day Moving Average 0.066
50-Day Moving Average 0.080
20-Day Moving Average 0.083
10-Day Moving Average 0.099
Average True Range 0.010
RSI (14) 57.81
ADX 22.4
+DI 28.612
-DI 25.694
Chandelier Exit (Long, 3 ATRs) 0.074
Chandelier Exit (Short, 3 ATRs) 0.091
Upper Bollinger Bands 0.117
Lower Bollinger Band 0.049
Percent B (%b) 0.75
BandWidth 82.892
MACD Line 0.006
MACD Signal Line 0.005
MACD Histogram 0.001
Fundamentals Value
Market Cap 77.52 Million
Num Shares 775 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -4.76
Price-to-Sales 0.00
Price-to-Book 27.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.100
Resistance 3 (R3) 0.100 0.100 0.100
Resistance 2 (R2) 0.100 0.100 0.100 0.100
Resistance 1 (R1) 0.100 0.100 0.100 0.100 0.100
Pivot Point 0.100 0.100 0.100 0.100 0.100
Support 1 (S1) 0.100 0.100 0.100 0.100 0.100
Support 2 (S2) 0.100 0.100 0.100 0.100
Support 3 (S3) 0.100 0.100 0.100
Support 4 (S4) 0.100